Preventive malaria treatment lowers anemia prevalence and improves attention span of children

July 10, 2008

Intermittent preventive treatment (IPT) for malaria lowers anaemia prevalence in and improves the attention span of schoolchildren in Africa. Such interventions could be a valuable addition to school health programmes in these low-income settings. These are the conclusions of authors of an Article in this week's edition of The Lancet.

Malaria is a major cause of death and disease in early childhood, yet its consequences for health and education during the school-age years remain poorly understood. Dr Siân Clarke, London School of Hygiene and Tropical Medicine (LSHTM), UK, and colleagues from LSHTM, Harvard University, USA, and Kenya did a randomised controlled trial of children aged 5-18 years from 30 primary schools in Western Kenya. They aimed to assess IPT in reducing anaemia (a common consequence of malaria infection) and improving classroom attention and education achievement in schoolchildren in an area of high malaria transmission.

A total of 2604 children received IPT, which consisted of three treatments of sulfadoxine-pyrimethamine in combination with amodiaquine at four month intervals, while 2302 received placebo. Children were diagnosed anaemic if a haemoglobin concentration below 110g/L was recorded in their blood. IPT reduced the occurrence of malaria infection after 12 months of the intervention, with prevalence of parasitaemia* in schools averaging <5% in the IPT group compared with 39.7% in the placebo group. Prevalence of anaemia was also lowered, averaging 6.3% in the IPT group and 12.6% in the placebo group, ie, children in the IPT group were around half as likely to become anaemic. Significant improvements were also seen in the IPT group in two classroom-based tests of sustained attention compared with placebo. No effect was shown on inattentive or hyperactive-compulsive behaviours or on educational achievement.

The authors conclude: "The pronounced effects of the IPT intervention on anaemia and malaria parasitaemia, and the effect on sustained attention, highlight the issue of the continued, and often unrecognised, malaria burden among school-aged children in Africa and the potential of school-based programmes for tackling the problem. Our findings also illustrate the possible gains of integrating malaria control into broader school health programmes."
-end-
Dr Siân Clarke, London School of Hygiene and Tropical Medicine (LSHTM), UK T) +44 (0) 207 299 4642 / +44 (0) 776 665 4045 E) sian.clarke@lshtm.ac.uk

*Notes to editors: parasitaemia is the presence of malaria parasites in the blood. However this is not a diagnosis of clinical malaria which also requires the presence of symptoms such as fever. Parasitaemia thus indicates malaria infection, but not disease. Malaria infections in this age group are usually asymptomatic.

http://multimedia.thelancet.com/pdf/press/malaria.pdf

Lancet

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.